ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
68,633.03
0.15%
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs Yen
156.965
0.00%
Brent Oil
81.965
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. Capstone Therapeutics Corporation (QB) (CAPS)

  7. Capstone Therapeutics Corporation (QB) (CAPS) ニュース

CAPS

Capstone Therapeutics (QB) (CAPS)

Capstone Therapeutics Corporation (QB)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:CAPS
日付受信時刻ニュースソース見出しコード企業名
2019/09/2605 : 01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2019/09/0922 : 02Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2019/08/2705 : 00Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2019/08/2106 : 25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2019/08/1322 : 02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2019/07/1105 : 02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2019/07/0403 : 52Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2019/07/0403 : 41Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2019/06/0105 : 48Edgar (US Regulatory)Statement of Ownership: Private Transaction (sc 13e3)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2019/06/0105 : 04Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2019/05/1401 : 03Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2019/03/2305 : 04Edgar (US Regulatory)Annual Report (10-k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2019/03/2122 : 03Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2019/03/2122 : 03Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2019/03/2122 : 03Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2019/03/2122 : 02Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2019/03/2006 : 02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2019/03/2005 : 01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2019/02/1406 : 46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2019/02/1203 : 02Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2019/02/0505 : 53Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2018/12/2902 : 38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2018/11/2107 : 25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2018/11/0705 : 33Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2018/08/1405 : 04Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2018/05/1906 : 02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2018/05/1205 : 03Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2018/05/0722 : 02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2018/03/0106 : 04Edgar (US Regulatory)Annual Report (10-k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
2018/02/0208 : 01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CAPSCapstone Therapeutics Corporation (QB)
 Showing the most relevant articles for your search:USOTC:CAPS

最近閲覧した銘柄

USOTC
RHHBY
Roche (QX)
USI
USTECH100
US Tech 100
NYSE
JPM
JP Morgan Chase
NASDAQ
AMZN
Amazon.com
NYSE
MRK
Merck
COIN
SOLUSD
Solana
AMEX
XLE
Energy Select Sector SPDR
NYSE
XOM
Exxon Mobil
USOTC
BASFY
BASF (QX)
CCOM
US500
US 500
NYSE
VZ
Verizon Communications
FX
USDEUR
US Dollar vs Euro
USOTC
BNPQY
BNP Paribas (QX)
NYSE
DIS
Walt Disney
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有